2013
DOI: 10.1016/j.supflu.2013.08.014
|View full text |Cite
|
Sign up to set email alerts
|

Nanoparticle formation of lycopene/β-cyclodextrin inclusion complex using supercritical antisolvent precipitation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
35
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 87 publications
(37 citation statements)
references
References 30 publications
2
35
0
Order By: Relevance
“…6. This trend has also been observed in a previous work [29]. When the process was carried out at a lower pressure, the particles tended to be larger and plate-like.…”
Section: Effect Of Pressure and Temperaturesupporting
confidence: 88%
See 1 more Smart Citation
“…6. This trend has also been observed in a previous work [29]. When the process was carried out at a lower pressure, the particles tended to be larger and plate-like.…”
Section: Effect Of Pressure and Temperaturesupporting
confidence: 88%
“…The solution-enhanced dispersion by supercritical fluids (SEDS) process is one of the modified SAS processes. In this process, the solution and SC-CO 2 are sprayed into a precipitator by a coaxial nozzle [11,[24][25][26][27][28] Water-soluble nanoparticles of the carotenoid/cyclodextrin complex were produced for synthesizing medicines by the SEDS process [29]. In this study, the organic solvent used was N,N-dimethylformamide (DMF), which is not approved anywhere in the world for use in food or supplement products.…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, some authors attempted SAS polymer/drug coprecipitation; but, the obtained particles were generally irregular [37] or coalescing [38,39], with broad particle size distributions [40,41], low drug loadings [12,42] and, in most cases, the demonstration of the effective coprecipitation was at least questionable [43][44][45][46]. In general, the authors had difficulties in demonstrating that a coprecipitate was formed and that drug properties were improved.…”
Section: Introductionmentioning
confidence: 99%
“…1 Among all the SAS-based particle fabrication techniques available, the SEDS process holds numerous advantages such as production of ultrafine particles with a narrow and uniform particle size distribution enhancing the dissolution rates of the APIs, high yields of polymer-based micro-and nano-sized composites, minimal agglomeration of particles, acceptable limits of residual solvents when operated at a reduced drying time, and ease of polymer coating over various particulate forms of APIs resulting in core-shell composites with sustained drug release ability, among others. [47][48][49][50] Moreover, this process is highly suitable for operating the water-soluble compounds by spraying the aqueous solutions along with the organic solvent separately through a coaxial three-compartment nozzle. 10,[51][52][53][54][55] However, there still exist some problems such as small processing capacity and easy blockage of the nozzle.…”
Section: Seds Processmentioning
confidence: 99%